This inventor holds 1 USPTO granted patent. Top assignee: The Upjohn Co.. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: The Innovative Contributions of Jeffrey A. Fleming
Introduction
Jeffrey A. Fleming is a notable inventor based in Augusta, MI (US). He has made significant contributions to the field of pharmaceuticals through his innovative processes. His work primarily focuses on the dehalogenation of steroids, which has important implications for medical applications.
Latest Patents
Fleming holds a patent for a process titled "9.alpha.-dehalogenation process." This invention involves improved methods for the dehalogenation of 9.alpha.-halosteroids to produce the corresponding 11.beta.-hydroxy steroids. These compounds are recognized for their utility in pharmaceuticals. The improvements in his process include the addition of the 9.alpha.-halo steroid to chromium and the use of catalytic amounts of chromium in the presence of a means of converting chromium (II) to chromium (III). This patent showcases his innovative approach to enhancing steroid production.
Career Highlights
Fleming is associated with The Upjohn Company, where he has been able to apply his expertise in the pharmaceutical industry. His work has contributed to advancements in steroid chemistry, which is crucial for developing effective medications. With a total of 1 patent, his contributions are significant in the realm of pharmaceutical innovations.
Collaborations
Fleming has collaborated with Joel E. Huber, a fellow professional in the field. Their partnership has likely fostered a productive environment for innovation and research within their company.
Conclusion
Jeffrey A. Fleming's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent for the 9.alpha.-dehalogenation process highlights his commitment to improving steroid production methods. Through his career at The Upjohn Company, he continues to make valuable contributions to the field.